Materia Medica Holding
Clinical trials sponsored by Materia Medica Holding, explained in plain language.
-
New cold treatment for kids shows promise in major trial
Symptom relief Recruiting nowThis study tests whether a medicine called raphamin can safely shorten cold and flu symptoms in children aged 3 to 12. About 374 children will receive either raphamin or a placebo. The main goal is to see how quickly symptoms like fever and congestion go away.
Phase: PHASE3 • Sponsor: Materia Medica Holding • Aim: Symptom relief
Last updated May 17, 2026 06:17 UTC
-
New drug raphamin aims to knock out sinus pain in days
Symptom relief Recruiting nowThis study tests whether Raphamin can quickly relieve symptoms of acute sinus infections (rhinosinusitis) in adults. About 552 people aged 18-75 with early-stage sinusitis will receive either Raphamin or a placebo. The main goal is to see if symptoms like stuffy nose, headache, a…
Phase: PHASE3 • Sponsor: Materia Medica Holding • Aim: Symptom relief
Last updated May 12, 2026 13:40 UTC
-
New cough syrup for tots: does it work?
Symptom relief Recruiting nowThis study tests a liquid medicine called Rengalin to see if it helps stop coughing in children aged 6 months to 3 years who have a viral cold. About 264 kids will take either Rengalin or a placebo (fake medicine) three times a day for a week. The main goal is to check if the cou…
Phase: PHASE3 • Sponsor: Materia Medica Holding • Aim: Symptom relief
Last updated May 11, 2026 20:46 UTC